Why Biocompatibility Should be Addressed by Every Medical Device Company

Global Medical Device Podcast · 4 Nov 2020 · 48m · Episode 166

What this episode covers

Mike Drues of Vascular Sciences joins host John Spear to discuss the critical importance of biocompatibility in medical device development, emphasizing that every device, including software, must address it. They analyze recent FDA guidances on skin-contact devices and Nitinol, warning against misinterpreting 'least burdensome' approaches as excuses to skip testing. Drues highlights the dangers of relying on purchasing controls or labeling for risk mitigation, citing the gynecological mesh litigation as a cautionary tale, and stresses the need for objective evidence and early engagement with experts.

Mentioned

Companies
Vascular Sciences, Greenlight Guru, FDA
Materials
Nitinol
Also
ISO 10993, 510 K

Other shows on the same ground, closest first.

  • Let's Combinate · 34m

    232 - MedTech Material Selection: Cost, Compliance, Sustainability, and Biocompatibility Risk

    Lucas Pianegonda, founder of Gradical, explains why medtech companies must move away from defaulting to legacy materials or molder preferences toward a structured, data-driven material selection framework. He details how early decisions on polymers like polycarbonate or PTFE impact total cost of goods, regulatory compliance, and sustainability, warning that late changes can cause multi-year delays and expensive retooling. The conversation covers the distinction between material grades and device-level biocompatibility, the risks of PFAS and additives, and the specific requirements of ISO 10993 for toxicological evaluation.

  • Let's Combinate · 25m

    093 - Combination Products Handbook Part 2: Supplier Management, Drug/Device Analytical Testing, Biologics, Digital/Connected Health and Changing Regulatory Landscape with Susan Neadle

    Susan Neadle, Principal Consultant at Combination Products Consulting Services LLC and author of 'The Combination Products Handbook', discusses advanced topics in combination product development with host Subi Saadeh. They cover supplier management nuances, specifically the risks of relying on 'medical grade' claims and the critical need for prior approval of supplier changes. The conversation also addresses analytical testing for biologics, highlighting compatibility issues between drug formulations and device constituents, and the evolving regulatory landscape for digital health and global combination products.

  • Embedded.fm · 1h 09m

    67: Software for Things That Can Kill People

    Hosts Chris White and Elecia White discuss the rigorous regulatory processes for safety-critical software, drawing on their experiences with the FAA (DO-178B) and FDA (510k, PMA) for medical devices and avionics. They explain how hazard analysis determines certification levels, the necessity of extensive documentation and traceability, and the tension between agile development and waterfall compliance. The conversation highlights the ethical responsibility of engineers to push back against unsafe deadlines, the use of hardware compartmentalization (FPGAs, voting systems) to ensure safety, and the legal liabilities associated with product failures.

  • Let's Combinate · 30m

    140 - Medical Device & Diagnostics Cybersecurity, 3rd Party Software, SBOM's, Evaluating Skill and Mindset with Christian Espinosa

    Christian Espinosa, CEO of Blue Goat Cyber, explains the unique cybersecurity challenges of medical devices, emphasizing that patient safety is the primary driver over data privacy. He details the importance of Software Bill of Materials (SBOM) and identifying third-party open-source components, such as the Shellshock vulnerability, to mitigate supply chain risks. Espinosa also discusses his hiring philosophy for Blue Goat Cyber, prioritizing practical aptitude and clarity of purpose over formal certifications or degrees.

  • The Pragmatic Embedded Podcast · 37m

    Agile Manifesto Pt. 1

    Hosts Jeff Gable and Luca Engineer discuss the first two principles of the Agile Manifesto, specifically 'Individuals and interactions over processes and tools' and 'Working software over comprehensive documentation,' with a focus on safety-critical industries like medical devices. They argue that while processes and documentation are necessary for regulatory compliance (FDA, MDR) and safety, they must be useful and not become 'cargo cult' rituals that hinder development. The conversation highlights the danger of overly granular specifications and emphasizes that code, infrastructure, and user interfaces can serve as valuable forms of documentation if they are clear and maintained.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.